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FOR\iJARD 
Between the months of June 1978 and June 1979, I was employed at 
Sunshine Terrace, a nursing home in Logan, Utah. In the year I spent 
there working as an orderly on the win9 for incontinent male patients, 
I was exposed to a lot of things of which I had previously been un­
aware. 
One which I observed was the liberal use of medications. At 
each nuses' station there was a small room which contained about 
six cabinets full of prescription drugs for the forty or so patients 
on that wing. At least every four hours the medication nurse \vould 
prepare a cart, filling a little cup with pill1 and capsules for each 
patient. Through questioning of these nurses I discovered that a lot 
of medications were solely prescribed to keep the patients sedated. 
One nurse told me that "the place vmuld be a madhouse" if all the 
people that were on sedation were suddenly taken off. In experiences 
I had with unruly, uncognizant patients I could understand the reason 
for such use of drugs. But I wondered if some people weren't over­
medicated. 
At the same time, I had heard and read much from the media about 
the liberal use of Valium, an anti-anxiety agent. I wondered if it was 
used extensively at the nursing ho�e. Aft�r investi�ating this, I 
found that there did not seem to be much use of it at Sunshine Terrace. 
But my curiosity had been piqued and I wanted to know if Valium use in 
America was as extensive as the sedative medications seemed to be at 
the nursing home. 
Originally I intended to focus on nursing home use of Valium. 
But initial research into the literature showed little had been done 
in that area. I focused my attention instead on claims of abuse of 
Valium by the general populace. The articles I had read and the pre­
sentations I had seen made Valium sound like a drug gone bad. So I 
made a literature search to see if I could ascertain the truth of those 
accusations. The report whdch follows is the result of that search. 
It is limited by the materials which were available to me. Actual 
laboratory research into the problem 1:JOul d have been more desirable 
but the limitations of riy fina.nces and 1 imited research experience 
made it impossible. 
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INTRODUCTION 
Valium (medical term: diazepam) is the most widely prescribed of 
any drug in the United States and has been for at least the last six 
years (1,2). According to one survey in 1972, prescriptions at that 
time for Valium and its sister drug Librium accounted for half of all 
psychotherapeutic drug use in the U.S. (1). Another analysis claims 
that Valium and Librium are used by one in ten American adults each 
year (3). Such staggering statistics, coupled with the current media 
accusations of overuse and abuse of not only Valium but a variety of 
prescription drugs, led me to examine the use and alleged abuse of 
Valium. 
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HISTORY 
A better understanding of the nature of the Valium controversy 
can perhaps be gained by an understandin9 of the history behind the 
birth of the drug. 
In 1952 chlorpromazine hydrochloride was synthesized and found 
to be an effective drug treatment for schizophrenia. Until that time, 
there had been no specific psychiatric drug treatments, only sedatives 
and stimulants. The discovery of chlorpromazine led to an intensified 
search for other specific chemical remedies to psychological problems. 
Drugs for depression were developed. Then, between the latter half 
of the 1950's and the first half of the 1960's, a number of sedatives 
specific for neurotic anxiety (termed "minor tranquilizers") v1ere 
introduced to the medical profession. Miltown (meprobamate) was the 
first, brought on the market in 1955 by Wallace Laboratories. 
Miltown was an immediate success. Encouraged by its acceptance, 
drug companies turned their efforts to developing other, more effective 
tranquilizers. In 1960 Hoffmann-LaRoche, a Swiss firm with its American 
base in Nutley, New Jersey, marketed the drug Librium, a member of the 
family of drugs called benzodiazepines. Th� story behind the discovery 
of this drug, and ultimately of its sister drug Valium, (or at least 
the story as it has reached us through interviews with its inventor, 
Leo Sternbach, by media journalists) is one of great interest (4,5). 
4 
Leo Sternbach is a polish-born Jew, and the son of a Cracow 
pharmacist. He attended college, receiving a Master's degree in 
pharmacy and a PhD in chemistry. Nazi anti-Semitic pressure prevented 
him from entering into academia so Sternbach turned to the pharmaceutical 
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job market. In 1939 he joined the Swiss firm of Hoffmann-LaRoche, 
centered in Basel. The following year he was transferred to the firm's 
Nutley, New Jersey plant, where he has remained since. 
Hhen the push came to develop new tranquilizers, Sternbach re­
membered a group of compounds he had studied in Cracow, the benzhep­
toxdiazines. He synthesized many of their derivatives and sent them 
for testing. None of them were effective and Sternbach turned to other 
things. A year and a half later in 1957 durin� a major clean-up of 
his lab, he discovered two samples from his benzheptoxdiazines work. 
He had not tried all of the possible reactions on these compounds and 
decided he would try them out before throwing them away. He tried 
a reaction with one of the samples and then sent it to be tested. 
To Sternbach's amazement, the new compound was very effective in 
reducing neurotic anxiety (6). Sternbach had had no idea that the 
compound would be an effective tranquilizer, he had only felt that he 
should not leave work undone. The structure of the new compound was 
determined in 1958 and it was named Librium. It was approved by the 
FDA and marketed in 1960. 
During the time that these legalities were being taken care of, 
Sternbach was busy trying out variations of his compound - 149 in all. 
One of these variations was shown to be much more potent than the 
others and was no more toxic. It was also found to have muscle-relaxant 
and anti-epileptic effects (7). The structure of this compound was 
established in 1'961 and it 11.Jas approved by the FDA and marketed in 1963 
as Valium. Although the discovery of this drug has been heralded as 
"the biggest pharmaceutical discovery that was ever made" (4) by Leo 
Sternbach himself, there are those 1t1ho worry about the abuse and/or 
overuse of Valium by a large number of Americans. 
USAGE 
The aforementioned wide use of Valium is not without a number of 
substantial positive benefits. The drugs which Valium and its com­
panion drugs (collectively termed the benzodiazepines) replace, such 
as barbiturates, meprobamate (Miltown), and hydroxyzine, are inferior 
to the benzodiazepines in many ways. They can be easily fatal if taken 
in overdose because they depress the respiratory center of the brain 
and the patient stops breathing. Tolerance to these drugs is achieved 
very rapidly and they are often abused. In addition, \•Ii thdrav,a 1 can 
be severe (1). 
The benzodiazepines, however, and Valium in particular, have side 
effects much milder than the above-mentioned dru9s but are just as 
effective (1). If used even in large amounts they have usually little 
or no overdose potential (1 ,8). Tolerance and withdrawal problems 
occur only in isolated cases (1 ,8). They have few side effects, 
interact with few other ,drugs (they do multiply the effects of alcohol 
like all sedatives), and in addition, their effects on the nervous 
system are immediate (1). 
The most common use of Valium is for neurotic an�iety (6). 
Anxiety is a difficult condition to assess in clinical terms. Webster's 
New \forld Dictionary describes it as a "worry or uneasiness about what 
may happen 11 (9). A well knm,m expert on psychotherapeutic drugs, 
David J. Greenblatt, describes it as 11a psychophysiologic response 
resembling fear but inappropriate to the reality of the perceived 
threat 1 1 (6). The professional description perhars adds more depth to 
understanding this condition, but it still remains a difficult prognosis 
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to analyze with accuracy. Patients may manifest anxiety in different 
ways. They may show fear, anger, irritability, apprehension, or just 
plain worry. They may exhibit a number of clinical symptoms. Among 
these are breathlessness, tremor, increased urination, fatigue, rest­
lessness, and difficulty in sleeping. But a patient may show none or 
all of these symptoms, in a very obvious way or barely perceptibly. 
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A patient may have anticipatory anxiety, relating to specific upcoming 
events in his life. But he may also experience "free-floating" anxiety, 
not associated with any particular situation (6). 
All of these variables make it difficult for the doctor to evaluate 
the amount of anxiety a patient is suffering. And the few actual 
clinical methods for quantifying anxiety are claimed to have serious 
limitations (6). So it is up to the doctor and the patient to analyze 
the amount of anxiety the patient has. In essence, subjective 
decisions based on the doctor's experience and clinical studies must 
be made. It is only in the patient's reaction to the prescribed 
dosage of anti-anxiety agent that the physician can monitor if the 
dosage is correct (8). 
Despite the nebulous character of quantifying anxiety, it is 
usually a recognizable condition in most patients. Most doctors treat 
it with minor tranquilizers (t,10,11). Considering that Valium is the 
most prescribed drug in America (1 ,2), and the most prescribed minor 
tranquilizer (1 ,10), it is likely the drug prescribed most often for 
anxiety. Whether this is the most desirable treatment for neurotic 
anxiety, however, is a question. 
Valium is used most widely as an anti-anxiety agent [minor tran­
quilizers are prescribed 84% of the time for anxiety conditions (10)], 
but it also has a variety of other uses. 
Experience and clinical studies have shown that Valium can act as 
an effective muscle-relaxe� (6,7). Although the mode and site of 
interaction are not known, the effects cannot be attributed solely to 
the depressive effects of the drug on the nervous system (those effects 
,�hich give it its anti-anxiety ability). For this reason, Valium is 
often used to treat severe muscle spasticity accompanying cerebral 
palsy, multiple sclerosis, Parkinsonism, cerebrovascular accidents, 
endoscopic procedures (in which tubes are inserted into body openings), 
and for pain and spasm associated with muscle strain, particularly in 
the back (12). Unfortunately, the doses required to effect muscle 
relaxation in most patients also produce drowsiness, uncoordination, 
and similar effects. Any patient required to perform tasks which 
require coordination and clear judgement should not be taking Valium 
in such large doses (12). However dangerous, Valium continues to be 
used for muscle relaxation (6,10,12) despite the fact that even the 
FDA will not endorse such use (13). 
When a patient suffers from uncontrolable repetitive seizures, 
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epileptic or otherwise, intravenous Valium seems to be the ideal drug (6,12). 
It has been most effective in preventing or arresting-seizures, espe-
cially those which are chemically (12) or electrically (7) induced. 
Again, it is not known for sure how Valium acts to prevent seizures, 
although theories have been presented (7,12). 
Most studies have shown Valium and its sister drugs to be as 
effective as any other kind of sedative or tranquilizer in suppressing 
symptoms of alcohol withdrawal (14). It has been shown to be effective 
in treating delirium tremens as well as the seizures which may accompany 
them (12). For these reasons, Valium is used as an agent to help cure 
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the chronic alcoholic from his dependence on alcohol. There is, however, 
no evidence and no guarentee that it is effective when used for out­
patient therapy to prevent the newly abstaining alcoholic from returning 
to alcoholism. In fact, since alcoholics are patients with a very 
strong drug-seeking behavion, there is no reason not to believe that 
they could substitute alcohol depen�P.nce for dependence on Valium (12). 
Valium is also used by some doctors as an aid to the birth 
process. Not only can it act to reduce the pain of delivery, but it 
also can reduce the requirement for opiates by the patient, enhance 
the amnesiac effects already imposed, and does not seem to produce 
any adverse effects upon the newborn child of any importance (6). 
Patients who are about to undergo any surgical procedure which 
requires general anesthesia are usually given a premedication sedative 
beforehand. Valium is often used as such a premedication (6). It 
has been well established as a useful tool for this procedure. 
In addition to the above-described uses of Valium, there are scores 
of other applications. New uses appear in the medical journals almost 
weekly. Valium is used to combat depression(the frequent companion of 
anxiety) (6,12). It has been used to help induce sleep (6,12). It has 
also been combined with various other drugs to alleviate problems as 
varied as reducing itching and reducing libidinal urges in homosexuals (15). 
It seems as if Valium has become the modern wonder drug to beat all 
wonder drugs: the panacea for all ills. 
ABUSE 
Despite its varied �pplications and side effects which are rare 
or weak as compared with other drugs taken for similar problems, there 
has been a torrent of information in the professional journals (and 
slick magazines) concerning abuse, overuse, and addiction to Valium. 
Before reviewing the above claims perhaps it would be helpful 
to define the terms being used. Abuse is used pri�arily to indicate 
an improper use (9). In dealing with drugs, and Valium in particular, 
abuse would generally refer to an unnecessary increase in the amount 
of a drug ingested. This can occur either in one session or in 
incremental amounts over an extended period. This increased intake 
is most often responsible for addiction, habituation, and tolerance 
to the drug. 
The terms addiction, habituation, tolerance, and dependence are 
often used interchangeably. This is not correct. Each term refers 
to a specific problem (16). Addiction refers to any true physiologic 
dependence on a drug. Dependence upon a drug is only true addiction 
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if withdrawal of the drug is followed by a form of withdrawal syndrome (16) 
in the patient characterized by true physiological changes. Habit-
uation, although it can occur concomitantly with addiction and generally 
follows long term drug exposure, can also occur by itself (16). It is 
a psychological, subjective desire for drugs and is accompanied by 
subjective unpleasant feelings, but is not associated with any real 
organic withdrawal syndrome (16). Tolerance, on the other hand, while 
it can occur with addiction or habituation, is a physiological condition 
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of adaptation to a drug and is not directly associated with dependence. 
An individual can build tolerance to a drug in two ways. Either the 
receptor sites in the body which the drug reacts with adapt to high 
concentrations of the drug and higher concentrations must be used to 
effect stimulation, or the body improves its ability to clear the 
bloodstream of the drug and higher doses must be given to achieve the 
same effect (16). 
In addiction , biological systems can also be affected by drug 
toxicity. Toxicity is the ability of a drug through a single dose or 
through extended use to build up compounds which can be fatal to an 
organism. 
Habituation is not the concern of this report. Being a psycho­
logical condition, it is not the drug but the personality of the user 
which is the crucial factor. Perhaps the perceived pain is just as 
strong, but true physical addiction does not occur. 
Addiction, however, is an issue of great concern as it applies 
to Valium use. The medical journals literally abound with cases of 
withdrawal syndromes exhibited in individuals deprived of Valium (17-24). 
The first case was reported in the American Journal of Psychiatry in 
1965 (17) only two years after Valium was marketed. Journal after 
journal and case after case document a seemingly appalling fact: 
Valium is indeed addictive and produces a withdrawal syndrome and 
psychosis. 
It would seem that the facts I mentioned earlier concerning mild 
side effects,compiled by those interested in showing the positive 
effects of Valium,have been proved false by this flood of case histories. 
This is, however, likely a fallacy. If we take into account the kind 
of people who have been used to provide these statistics, a limiting 
condition appears. vJith almost no exceptions, every person used in a 
case study to document Valium addiction has been a long time drug user 
and had been ingesting large doses of Valium, far exceeding any pre­
scribed amount (16,18-24). In addition, many of these individuals are 
polydrug users, people who abuse a variety of drugs, including alco­
hol (20,22,23). 
So although these case reports represent valid observations of 
addiction, they do not an.rear to be a true indication of the extent of 
addiction to Valium. They seem to represent a small minority, often 
those people who have exhibited a drug-seeking, drug-abusing person-
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ality (8,16). True addiction is probably a very unusual occurance (12,16) 
and likely occurs primarily among those with such addiction-prone 
personalities (16). 
Support for this belief comes from a study carried out in Cincinnati 
in 1973 (25). In this six month study, patients admitted to a psychiat­
ric ward were allowed to seek and obtain Valium simply on demand. 
When the results were analyzed, it was found that the patients chose 
to use the drug only when they felt anxious. It was used only moderately 
by them: tvienty-seven percent of the patients never used the drug and 
through the entire six months a request was made only on the average 
of once every three days. So under conditions where psychiatric patients 
with problems of anxiety were allowed free use of the drug, only mod­
erate use was observed. This evidence would tend to support claims that 
addiction to Valium is an unusual condition. Of course, being in a 
hospital situation may have inhibited some patients in their drug requests. 
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There are also arguments that what is diagnosed as Valium with­
drawal may many times actually be the return of symptoms for which the 
drug was taken for in the first place (8,16). If the anxiety was severe 
enough, some experts consider it difficult to distinguish return of 
symptoms from a withdrawal reaction. If this is true, many supposed 
cases of addiction could be cast into doubt. 
It also seems to be the feeling of the medical profession that the 
majority of their patients do not voluntarily increase their doses nor 
have any problems when they come off the drug (1 ,8,16). Physician and 
patient seem to be content with its use. Although these are very sub­
jective facts, they may have some creedence, being based on the 
physician's first-hand experience. 
Concerning tolerance to Valium, there is also sufficient evidence 
to indicate that a certain degree of tolerance to the side-effects of 
Valium does occur. A high amount of tolerance, however, has not been 
found (16). Also, since it is not yet known if tolerance also develops 
to the therapeutic effects of Valium, the side-effect tolerance is not 
necessarily unfavorable (16). 
As far as toxicity is concerned, little research has been done 
\vith Valium. One study, carried out at the Univeristy of Utah (26) 
considered 1,239 deaths reported at 27 merlical examiner or coroners 
offices across the U.S. and Canada which had involved Valium in any way. 
It was found that death was generally caused by ingestion of a number 
of drugs and not just Valium. Although there was a high occurance of 
Valium use among the cases studied, its importance toxicologically 
in the fatalities was considered minimal. 
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The preceeding facts seem to indicate that under the easily definable, 
clincal limits of abuse as previously outlined, Valium is not an abused 
drug, or at least not to the extent that would make it more dangerous 
than any other drug. Its clinical side effects are truly minimal as 
compared expecially with the drugs it replaces. The major clinical 
concern, addiction, (with its associated withdrawal syndrome) has been 
documented but seems to he a serious problem primarily among abuse-prone 
individuals who already have a considerable history in drug and alcohol 
abuse.(Such individuals also abuse a number of other prescription druqs.) 
In general, although the information concerning clinical abuse of Valium 
is certainly not complete, the majority of the facts gathered seem to 
indicate that it is not abused, at least not by the definition the 
scientific community has given it. 
The question remains, however, should abuse be as narrowly defined 
as it seems to have been in the literature cited? Although there are 
no written criteria designating what the limits of abuse are, it appears 
that a cautionary generalization can be made. In all the data I gathered 
concerning the abuse of Valium, the term "abuse" v1as always used to 
designate a clinically observable situation, where intake of the drug 
had proceeded to the point that it not just hampered, but almost halted 
the patient's ability to function. 
There could be a less severe, but likely far more common form of 
abuse of Valium. Although it appears that the term 1abuse' is primarily 
used in cases where the clinician can document physical change, there 
is a whole spectrum of usage of the drug. 
Although it is not of the same severity as addiction, overuse of 
Valium could also be termed abuse. If abuse is defined as incorrectly 
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using an object, then any amount of excessive intake, whether prescribed 
by a doctor or initiated solely by the oatir.nt, can also be considered 
abuse. 
The whole question of overuse and its ramifications, however, is 
not well documented. Since it is not an organically measurable con­
dition, consideration of it can be highly subjective. What one clinician 
terms overuse of a drug may be considered as an insufficient dosage by 
another. Although blatant overuse would likely be an identifiable con­
dition, much of the spectrum of overuse would be in a grey area, where 
personal philosophies and medical attitudes would do much to color a 
physician's judgements concerning correct dosage. There appears to have 
been little research of a professional nature done specifically on the 
question of overuse, perhaps because of these complications. 
The complexities of this situation do, however, bring another fact 
to light. There are two identifiable kinds of overuse of Valium. 
First, there is over-prescription by the doctor. - Tnere are a few 
studies concerning over prescription of Valium by physicians, but also 
much supportive information in the form of studies do�e on prescription 
patterns in America (3,10,11 ,27-30). The second kind of overuse 1s 
overuse by the patient. If a patient has a non-monitored source of 
Valium or received simultaneous prescriptions from a number of unknowing 
doctors, the professional community has no way of keeping tabs on 
patient use. Under these conditions a patient could elevate Valium 
intake to any level he chooses. This is certainly a possibility and 
likely a major factor in abuse-Overuse. 
I was unable to find, however, professional documentable proof 
of patient use. The media has done much to popularize the attraction 
of Valium to Americans, examples of such being 11 Valumania 11 by the New 
York Times Magazine of February 1976, 11The Drug Everybody Loves" in
Family Health of January 1978, and a 60 Minutes special report on 
Valium in October of 1977. These accusations of patient (and physi­
cian) overuse, however, are not documented nor do they use acceptable 
survey methods in their research and thus we have no way of knowing 
just how representative they truly are. This is an area of drug use 
in America which certainly needs to be more heavily monitored so that 
the professional community, and the public as a whole, can be more 
aware of patient use of prescribed drugs. 
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As mentioned, however, there are some statistics concerning over­
prescription of Valium by physicians. First, let us look at prescribing 
patterns as documented in area and nationwide professional surveys. 
There seem to be as many conclusions concerninq psycotherapeutic 
drug use, and Valium in particular, as there are studies (3,10,11,27-30). 
Nonetheless, a few repetitive conclusions appear in virtually all studies 
made. First, psychotherapeutic drug use is a widespread phenomenon, 
with at least 10% of the population involved (3,28), not only in America 
but in many other nations (28). The statisitcs cited at the beginnin9 
of this paper would tend to support these results. Second, it appears 
that general practitioners are the major orAscribers of minor tran­
quilizers (3,11,30). 
These facts in themselves prove nothing. The fact that psycho­
therapeutic drug use is prevalent does not necessarily indicate that 
these drugs are being over-prescribed. It also tells us nothing about 
patterns of use, whether the majority of people are habitual users or 
only sporadic consumers of such drugs. The fact that the general 
practitioner, the physician least specialized in use of drugs for 
psychological problems, prescribes the most psychotherapeutics also 
does not tell us that he is prescribing them inconsistently, although 
there is certainly a possibility. 
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There are some noted studies, however, which delve into such ques­
tions. The answers they arrive at are varied, but do lie across a 
spectrum of belief of which we can deliniate the outlines. At the 
far right of the spectrum I discovered researchers, notably H. J. Parry 
et al, National Patterns of Psychotherapeutic Drug Use (11), who have 
concluded that although use is extensive there seems to be little abuse 
and overuse involved. Most outpatient prescriptions, Parry's study 
discovered, are for nonpsychiatric disorders (11). He also concluded 
that the largest proportion of users had taken the drugs irregularly, 
sporadically, or if regularly, only for short periods of time (11). 
Such results support those with an attitude of satisfaction with 
psychotherapeutic drug use in America. They seem to indicate that 
although use is high, it seems to be correct in the majority of cases. 
They bolster the attitude that the general physician is making good 
value judgements in his prescribing habits. 
There are those researchers, however, who have come to drastically 
different conclusion. A number of studies indicate that minor tranquil­
izers are the drug prescribed most fr�quently, but with the least 
justification, mostly by general practitioners and internists (3,27,29). 
One study states that duration of treatment seems to be prolonged and 
unnecessary (30). These researchers are disturbed with the use of 
psychotherapeutic drugs and urge much caution in prGscribing and in 
patient monitoring. Their results show that the general practioner 
seems to be too careless with his prescription and that psychothera­
peutic drugs are not needed to the extent they are being prescribed. 
Such directly conflicting results from surveys of drug use, all 
published in major medical journals, leads to concern. What exactly 
is the status of psychotherapeutic drug use in America? Is there 
cause for alarm as the ''slicks" and some researchers would have us 
believe? Or is the whole issue blown out of proportion? 
It is a fact, however, that the Drug Enforcement Administration, 
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on FDA approval after years of study and congressional discussion, ruled 
in 1975 that a prescription for Valium or Librium will be valid for only 
six months and can only be refilled five times (31). The DEA itself 
said that continued consumption of high doses could lead to addiction. 
The FDA commented that easy availability of Valium and Librium could 
be contributing to raising their abuse potential (31). These statements 
and rulings by the government indicate their concern for the abuse 
potential of Valium. They seem to feel that there is over-prescription 
and they are attempting to control it. 
So, although proof is insubstantial to indict Valium as being 
improperly used, there seems to be concern nationwide. It seems that 
many people, swayed either by the "scare" articles in slick magazines 
or by the negative scientific evidence, however inconclusive, feel that 
we are an overmedicated society and that Valium is a prime example. 
In this context Valium becomes more than a drug; it is a symbol. 
The battle for restricted Valium use as it has taken place in congress, 
with LaRoche pouring millions into their lobby (32), becomes a battle 
between attitudes, and perhaps a battle deciding which faction, scien­
tific community, government, media, or business, has more power. 
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One fact conceded by almost all researchers though, is that there 
is an obvious need for more study and understanding (10,11,27-30). 
Considering the variety of opinions, it appears important to have more 
conclusive work done which would support one opinion or the other. If 
there is indeed overuse of Valium and the minor tranquilizers, it is 
indicative of social trends in America, moving toward finding simple, 
quick answers and away from more time consuming solutions, which perhaps 
are more permanent. 
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COMMENTS AND CONCLLJSinN 
It seems to me in this consideration of Valium use·and abuse that 
we are considering two opposing schools of thought. The first is what 
could be termed "utilitarian happiness". This group consists of those 
who feel that life should be free of stress. Any tool which can rid 
us of problems and relieve stress is to be welcomed. If something 
\.'JOrks, 1t1hy not use it? Such people would see no dignity or virtue in 
tolerating physical or mental discomfort. If increasing use of a drug 
helps in coping with social stresses, it should increase personal 
happiness. 
The opposing view has its roots in the puritan ethic. Upholders 
of this view would consider it a "cop out" to use drugs as a way of 
relieving stress. They 1t1ould maintain that society is over-drugged, 
where people swallow pills to forget their problems but never get to 
the causitive source. 
It seems to me that these veiwpoints mirror the ideological battle 
in human society beb,een the philosophies of here-and-now happiness 
versus the belief in emotional growth, searching not for happiness 
but "salvaltion". Depending on ones viev1point, there is a different 
set of judgemental values (varying 1,1ith the strength of one's position 
left or right) with which one would make decisions concerning drug 
usage. Those in the "happiness" camp would not consider dosage ex­
treme if it alleviated stress and made the patient content. Those of 
the opposing view would believe that different methods should be used 
to solve the problem, perhaps considering drug treatment totally 
unnecessary if replaced with an attitude of concern and desire to listen 
to patient problems by the physician. Two studies suggested exactly 
such a treatment (1,3). They hypothesized that perhaps all that was 
necessary to really help patients with anxiety problems was to spend 
more time with them and discuss their problems. One study indicated 
that this method had positive results in its setting (33). 
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If my theory is true, then analyses of prescription patterns 
could and would be considered in different contexts by the "opposing 
views" and perhaps this would be a causitive force in the diversity of 
conclusions reached by those conducting the various drug use surveys. 
If true, then perhaps even further studies would bring no conclusive 
evidence to either camp. 
It \•Jould appear that my study of this subject has resulted in a 
stand off. There are more questions now than in the beginning and 
certainly few answers. But perhaps the tnuth about the abuse of 
Valium is not the most important thing that I learned in researching 
this topic. I feel that I have learned something about the nature of 
research and problem solving. 
In researching a single problem, I realized that a whole new group 
of problems arise usually, rather than finding a solution to the original. 
But this is not necessarily a negative thing. In discovering and shaping 
new problems, the nature of my original question and some of its 
ramifications becomes clearer. I may feel farther away from the light 
at the end of the tunnel, but at least I now have a partial map of 
my trail. 
I have also learned about the difficulties entailed in researching 
the work of others. Not only is there difficulty in gathering and 
organizing references, but once I had the material, it was difficult 
to find the exact research I wanted. The superiority of original 
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research compared to gathering sources was greatly emphasized. 
Research itself, however, is not beyond reproach. The attitude 
with which a researcher attacks a problem and the way in which he 
handles it seem to clearly color the results. Just because an article 
in a major journal says that something is so does not make it a fact. 
If this were so, I think you could prove just about anything you wanted 
to with II facts 11• 
Last, but certainly not least, the exposure that the media gives 
to a subject can certainly be slanted or exaggerated. True addiction 
to Valium is certainly much less widespread than the media would have 
us believe. But this does not mean that the media should be disregarded 
as pure sensationalists. The media rrovides an avenue for questions 
to be asked that perhaps an organization (like the AMA) would not ask 
itself, providing the impetus for investigation into a problem. Per­
haps it was questions by the media which initiated resarch into 
Valium and minor tranquilizer abuse by the scientific community. And, 
if not for certain media accusations which came to my attention, I 
likely never would have studied Valium or written this paper. 
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